MARKHAM, ON, Oct. 8. 2015 /CNW/ – Canadian transplant researchers will receive an additional boost thanks to a new collaboration between Astellas Pharma Canada, Inc. (Astellas) and the Canadian Society of Transplantation (CST).
Astellas has committed $200,000 over a two-year period to launch the Astellas CST Clinical Research Grant Program. This program will support Canadian investigators in the field of transplantation through a peer-reviewed research grant competition, with the ultimate goal of improving long-term outcomes and quality of life for transplant recipients. The primary focus for the inaugural year will be clinical research in solid organ transplantation.
Full Article Here: www.newswire.ca
The post Markham Based Astellas Pharma Canada, Inc. Partners with Canadian Society of Transplantation to offer Clinical Research Grants appeared first on Toronto Area's Tech Hub.